In older adults, RSV can cause severe breathing problems, particularly in those who are frail or have other health conditions. For a small number of people who are at risk of more severe respiratory disease, RSV infection might cause pneumonia (infection of the lungs) or even death.
Respiratory syncytial virus (RSV) vaccination for older adults
All medicines (including vaccines) are tested for safety and effectiveness before they are allowed to be used. Once they are in use, their safety continues to be monitored by the Medicines and Healthcare Products Regulatory Agency (MHRA).
The RSV vaccine has passed strict safety standards for use in the UK and has been shown to be very safe.
As with all vaccines, any reports of side effects are closely monitored and reviewed.
Respiratory syncytial virus (RSV) vaccination for older adults